 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/12/2024 |
$16.27 |
$16.37 |
$15.28 |
$15.44 |
1.43M | | 04/15/2024 |
$15.60 |
$15.60 |
$15.06 |
$15.32 |
846.20K | | 04/16/2024 |
$15.22 |
$15.74 |
$15.06 |
$15.63 |
1.94M | | 04/17/2024 |
$12.96 |
$13.42 |
$10.92 |
$12.57 |
4.32M | | 04/18/2024 |
$12.24 |
$13.50 |
$12.20 |
$13.04 |
1.76M |
|
|
| Sage Therapeutics is a biopharmaceutical company focused on developing and commercializing medicines with the potential to transform the lives of people with debilitating disorders of the brain. Co.'s principal product, ZULRESSO, is a proprietary intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. Co.'s other product candidate is zuranolone (SAGE-217), an oral compound being developed for certain affective disorders, including major depressive disorder, and PPD. Co. has a portfolio of other compounds that target GABAA receptors, including SAGE-324. SAGE-324 is a GABAA receptor positive allosteric modulator intended for chronic oral dosing. | |
|
Sage Therapeutics (SAGE) has the following price history information. Looking back at SAGE historical stock prices for the last five trading days, on April 12, 2024, SAGE opened at $16.27, traded as high as $16.37 and as low as $15.28, and closed at $15.44. Trading volume was a total of 1.43M shares. On April 15, 2024, SAGE opened at $15.60, traded as high as $15.60 and as low as $15.06, and closed at $15.32. Trading volume was a total of 846.20K shares. On April 16, 2024, SAGE opened at $15.22, traded as high as $15.74 and as low as $15.06, and closed at $15.63. Trading volume was a total of 1.94M shares. On April 17, 2024, SAGE opened at $12.96, traded as high as $13.42 and as low as $10.92, and closed at $12.57. Trading volume was a total of 4.32M shares. On April 18, 2024, SAGE opened at $12.24, traded as high as $13.50 and as low as $12.20, and closed at $13.04. Trading volume was a total of 1.76M shares.
SAGE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Sage Therapeutics shares, starting with a $10,000 purchase of SAGE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/21/2014 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$30.00 |
|
| End price/share: |
$13.04 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-56.55% |
|
| Average Annual Total Return: |
-8.19% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$4,346.62 |
|
| Years: |
9.75 |
|
|
|
| Date |
Close |
| 04/12/2024 | $15.44 | | 04/15/2024 | $15.32 | | 04/16/2024 | $15.63 | | 04/17/2024 | $12.57 | | 04/18/2024 | $13.04 |
|
|
Free SAGE Email Alerts:
